OncoMed Pharmaceuticals, Inc. (Nasdaq: OMED) announced that Jakob Dupont, M.D., has resigned as the company’s Senior Vice President and Chief ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE